Straits Times Index
3,320.92 +13.02 (+0.39%) Nikkei
39,103.22 +486.12 (+1.26%) Hang Seng
18,868.71 -326.89 (-1.70%) FTSE 100
8,347.67 -22.66 (-0.27%) Bitcoin USD
69,586.84 -439.09 (-0.63%) CMC Crypto 200
1,517.52 +14.86 (+0.99%)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ)
| Previous close | 305.00 |
| Open | 312.52 |
| Bid | 309.72 x 0 |
| Ask | 309.95 x 0 |
| Day's range | 304.58 - 310.53 |
| 52-week range | 253.48 - 325.00 |
| Volume | |
| Avg. volume | 3,607,689 |
| Market cap | 375.856B |
| Beta (5Y monthly) | 0.09 |
| PE ratio (TTM) | 30.91 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 10.30 (3.38%) |
| Ex-dividend date | 28 May 2024 |
| 1y target est | N/A |
- PR Newswire Asia
Mindray Expands Its Cardiac Biomarker Portfolio with Cutting-Edge hs-cTnI and NT-proBNP Assays, Empowering Enhanced Cardiovascular Diseases Care
Mindray (SZSE: 300760), a global leader in medical devices and solutions, introduces high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The additions have enhanced Mindray's diverse portfolio of cardiac biomarkers for cardiovascular diseases (CVDs) diagnosis and management.
- CNW Group
Mindray Introduces Innovative Upgrades to A Series Anaesthesia Systems for Enhanced Patient Safety and Efficiency
Mindray (SZSE: 300760), a global leader in providing advanced medical device solutions, has unveiled upgrades to its A7 and A5 anaesthesia systems under the A Series Anaesthesia. These enhancements incorporate innovative technologies that empower anaesthesiologists to deliver precise anaesthesia, leading to greater patient safety and efficiency throughout the perioperative period.
- CNW Group
Mindray and Operation Smile Begin 10-Year Partnership to Improve Healthcare for Vulnerable Communities
Mindray, a leading global provider of medical devices and solutions and Operation Smile, a global nonprofit dedicated to transforming the lives of patients and their communities by increasing access to safe surgery and providing high-quality cleft surgery and comprehensive care, today announced a new 10-year partnership. This solidifies a strategic partnership between the two organizations to collaborate on improving the quality of health care and providing life-changing medical interventions to
